Show simple item record

dc.contributor.authorBowen, Cai
dc.contributor.authorOstrowski, Michael C
dc.contributor.authorLeone, Gustavo
dc.contributor.authorGelmann, Edward P
dc.date.accessioned2019-09-23T20:10:16Z
dc.date.available2019-09-23T20:10:16Z
dc.date.issued2019-08-15
dc.identifier.citationBowen, C., Ostrowski, M. C., Leone, G., & Gelmann, E. P. (2019). Loss of PTEN Accelerates NKX3. 1 Degradation to Promote Prostate Cancer Progression. Cancer Research, canres-4110.en_US
dc.identifier.issn0008-5472
dc.identifier.pmid31213464
dc.identifier.doi10.1158/0008-5472.CAN-18-4110
dc.identifier.urihttp://hdl.handle.net/10150/634563
dc.description.abstractNKX3.1 is the most commonly deleted gene in prostate cancer and a gatekeeper suppressor. NKX3.1 is a growth suppressor, mediator of apoptosis, inducer of antioxidants, and enhancer of DNA repair. PTEN is a ubiquitous tumor suppressor that is often decreased in prostate cancer during tumor progression. Steady-state turnover of NKX3.1 is mediated by DYRK1B phosphorylation at NKX3.1 serine 185 that leads to polyubiquitination and proteasomal degradation. In this study, we show PTEN is an NKX3.1 phosphatase that protects NKX3.1 from degradation. PTEN specifically opposed phosphorylation at NKX3.1(S185) and prolonged NKX3.1 half-life. PTEN and NKX3.1 interacted primarily in the nucleus as loss of PTEN nuclear localization abrogated its ability to bind to and protect NKX3.1 from degradation. The effect of PTEN on NKX3.1 was mediated via rapid enzyme-substrate interaction. An effect of PTEN on Nkx3.1 gene transcription was seen in vitro, but not in vivo. In gene-targeted mice, Nkx3.1 expression significantly diminished shortly after loss of Pten expression in the prostate. Nkx3.1 loss primarily increased prostate epithelial cell proliferation in vivo. In these mice, Nkx3.1 mRNA was not affected by Pten expression. Thus, the prostate cancer suppressors PTEN and NKX3.1 interact and loss of PTEN is responsible, at least in part, for progressive loss of NKX3.1 that occurs during tumor progression. SIGNIFICANCE: PTEN functions as a phosphatase of NKX3.1, a gatekeeper suppressor of prostate cancer.en_US
dc.description.sponsorshipFalconwood Foundation; NCI [P01 CA154293]; CCSG [P30 CA013696-36]en_US
dc.language.isoenen_US
dc.publisherAMER ASSOC CANCER RESEARCHen_US
dc.rights© 2019 American Association for Cancer Research.en_US
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/
dc.titleLoss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progressionen_US
dc.typeArticleen_US
dc.contributor.departmentUniv Arizonaen_US
dc.identifier.journalCANCER RESEARCHen_US
dc.description.note12 month embargo; published online: 18 June 2019en_US
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.en_US
dc.eprint.versionFinal accepted manuscripten_US
dc.source.journaltitleCancer research


Files in this item

Thumbnail
Name:
NKX3.1_PTEN_Cancer_Res_final-U ...
Size:
2.669Mb
Format:
PDF
Description:
Final Accepted Manuscript

This item appears in the following Collection(s)

Show simple item record